Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNano Genomics Inc (BNGO) vs Carparts.Com Inc (PRTS) Price & Performance

BioNano Genomics IncTrade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

BioNano Genomics Inc vs Carparts.Com Inc — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while Carparts.Com Inc trades at $6.01 (market cap $47.74M). The key difference: Carparts.Com Inc is far larger — about 3.6× BioNano Genomics Inc's market cap, and Carparts.Com Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.

BNGOPRTS
Market Cap
$13.20M$47.74M
Sector
HealthConsumer Cyclical
52-Week High
$4.92$11.40
52-Week Low
$1.09$3.88
Enterprise Value
$15.81M$62.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNano Genomics Inc

Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.

BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.

Carparts.Com Inc

CarParts.com (PRTS) trades at $5.66, down 3.58% today, with a bearish technical signal despite recent positive developments including Nasdaq compliance and a $25 million credit facility. The company shows improving operational metrics with three consecutive earnings beats, though it remains unprofitable with negative margins and cash flow. Valuation metrics appear attractive with P/S of 0.07 and P/B of 0.77, but fundamental challenges persist.

While analyst sentiment is positive (60% buy ratings) and recent corporate actions provide stability, PRTS faces significant execution risks amid declining revenue and persistent losses. The stock offers speculative appeal for turnaround investors but requires careful monitoring of cash burn and profitability improvements. Near-term catalysts include Q2 2026 earnings results expected at -$0.85 EPS.

Returns comparison

Trailing returns across standard periods

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS